1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Deep, S. Walker III, K.P. Shu, Z. Hinck, A.P. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 42 10126 10139 10.1021/bi034366a 12939140 Solution structure and backbone dynamics of the TGF-beta type II receptor extracellular domain 2003 10.2210/pdb1plo/pdb pdb_00001plo 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 13810.606 TGF-beta receptor type II 2.7.1.37 N19A 1 man polymer TGFR-2, TGF-beta type II receptor no no VTDNAGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAA SPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPD VTDNAGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAA SPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPD A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia Escherichia coli sample TGFBR2 9606 Homo sapiens 469008 Escherichia coli BL21(DE3) BL21(DE3) Plasmid pET32a database_2 pdbx_nmr_spectrometer pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2003-09-23 1 1 2008-04-29 1 2 2011-07-13 1 3 2021-10-27 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_spectrometer.model _struct_ref_seq_dif.details Backbone and Sidechain 1H, 13C, and 15N NMR Chemical Shift Assignments RCSB Y RCSB 2003-06-08 REL REL This structure was determined by refining simultaneously against NOE, J-coupling, dihedral angle, and residual dipolar coupling constraints structures with acceptable covalent geometry, structures with favorable non-bond energy, structures with the least restraint violations, structures with the lowest energy 50 10 3D_15N-separated_NOESY 3D_13C-separated_NOESY 4D_13C-separated_NOESY 3D 15N edited, 13C-edited 1H-1H noesy 3D 15N-edited,15N-edited 1H-1H noesy 1H-15H 1-bond residual dipolar coupling (2D IPAP-HSQC) 13C-13CO residual dipolar coupling (3D (HA)CA(CO)NH 13Calpha-13CO residual dipolar coupling (3D Ca-coupled HNCO) 25mM sodium acetate, 25mM NaCl, pH 5.5 5.5 ambient 300 K 25mM sodium acetate, 25mM NaCl 5.1 ambient 300 K 25mM sodium acetate, 25mM NaCl 5.5 ambient 313 K structures are based on a total of 1583 constraints, 1168 are NOE distance, 138 are dihedredral angle, 58 are 3JHNHa coupling constant, 219 are residual dipolar couplings, substructure distance geometry, full structure distance geometry-simulated annealing; torsion angle dynamics 1 fewest violations, lowest energy 1mM ecTbR2 U-15N, 25mM sodium acetate, 25mM NaCl, 95% H2O, 5% D2O 95% H2O/5% D2O 1mM ecTbR2 U-15N, 13C, 25mM sodium acetate, 25mM NaCl, 95% H2O, 5% D2O 95% H2O/5% D2O 1mM ecTbR2 U-15N, 13C, 25mM sodium acetate, 25mM NaCl, 99.99% D2O 99.99% D2O 1mM ecTbR2 U-15N, 25mM sodium acetate, 25mM NaCl, 4% (w/v) 1,2-di-O-hexyl-sn-glycero-3-phosphocholine (6-O-PC) and 1,2-di-O-tetradecyl-sn-glycero-3-phosphocholine (14-O-PC) mixed in a molar ratio of 1:3, 95% H2O, 5% D2O 95% H2O/5% D2O 1mM ecTbR2 U-15N, 13C, 25mM sodium acetate, 25mM NaCl, 4% (w/v) 1,2-di-O-hexyl-sn-glycero-3-phosphocholine (6-O-PC) and 1,2-di-O-tetradecyl-sn-glycero-3-phosphocholine (14-O-PC) mixed in a molar ratio of 1:3, 95% H2O, 5% D2O 95% H2O/5% D2O Clore, G.M., Kuszewski, J., Schwieters, C.D., Tjandra, N. refinement XPLOR_NIH 1.06 600 Bruker DRX 500 Bruker AVANCE VAL 15 n 1 VAL 15 A THR 16 n 2 THR 16 A ASP 17 n 3 ASP 17 A ASN 18 n 4 ASN 18 A ALA 19 n 5 ALA 19 A GLY 20 n 6 GLY 20 A ALA 21 n 7 ALA 21 A VAL 22 n 8 VAL 22 A LYS 23 n 9 LYS 23 A PHE 24 n 10 PHE 24 A PRO 25 n 11 PRO 25 A GLN 26 n 12 GLN 26 A LEU 27 n 13 LEU 27 A CYS 28 n 14 CYS 28 A LYS 29 n 15 LYS 29 A PHE 30 n 16 PHE 30 A CYS 31 n 17 CYS 31 A ASP 32 n 18 ASP 32 A VAL 33 n 19 VAL 33 A ARG 34 n 20 ARG 34 A PHE 35 n 21 PHE 35 A SER 36 n 22 SER 36 A THR 37 n 23 THR 37 A CYS 38 n 24 CYS 38 A ASP 39 n 25 ASP 39 A ASN 40 n 26 ASN 40 A GLN 41 n 27 GLN 41 A LYS 42 n 28 LYS 42 A SER 43 n 29 SER 43 A CYS 44 n 30 CYS 44 A MET 45 n 31 MET 45 A SER 46 n 32 SER 46 A ASN 47 n 33 ASN 47 A CYS 48 n 34 CYS 48 A SER 49 n 35 SER 49 A ILE 50 n 36 ILE 50 A THR 51 n 37 THR 51 A SER 52 n 38 SER 52 A ILE 53 n 39 ILE 53 A CYS 54 n 40 CYS 54 A GLU 55 n 41 GLU 55 A LYS 56 n 42 LYS 56 A PRO 57 n 43 PRO 57 A GLN 58 n 44 GLN 58 A GLU 59 n 45 GLU 59 A VAL 60 n 46 VAL 60 A CYS 61 n 47 CYS 61 A VAL 62 n 48 VAL 62 A ALA 63 n 49 ALA 63 A VAL 64 n 50 VAL 64 A TRP 65 n 51 TRP 65 A ARG 66 n 52 ARG 66 A LYS 67 n 53 LYS 67 A ASN 68 n 54 ASN 68 A ASP 69 n 55 ASP 69 A GLU 70 n 56 GLU 70 A ASN 71 n 57 ASN 71 A ILE 72 n 58 ILE 72 A THR 73 n 59 THR 73 A LEU 74 n 60 LEU 74 A GLU 75 n 61 GLU 75 A THR 76 n 62 THR 76 A VAL 77 n 63 VAL 77 A CYS 78 n 64 CYS 78 A HIS 79 n 65 HIS 79 A ASP 80 n 66 ASP 80 A PRO 81 n 67 PRO 81 A LYS 82 n 68 LYS 82 A LEU 83 n 69 LEU 83 A PRO 84 n 70 PRO 84 A TYR 85 n 71 TYR 85 A HIS 86 n 72 HIS 86 A ASP 87 n 73 ASP 87 A PHE 88 n 74 PHE 88 A ILE 89 n 75 ILE 89 A LEU 90 n 76 LEU 90 A GLU 91 n 77 GLU 91 A ASP 92 n 78 ASP 92 A ALA 93 n 79 ALA 93 A ALA 94 n 80 ALA 94 A SER 95 n 81 SER 95 A PRO 96 n 82 PRO 96 A LYS 97 n 83 LYS 97 A CYS 98 n 84 CYS 98 A ILE 99 n 85 ILE 99 A MET 100 n 86 MET 100 A LYS 101 n 87 LYS 101 A GLU 102 n 88 GLU 102 A LYS 103 n 89 LYS 103 A LYS 104 n 90 LYS 104 A LYS 105 n 91 LYS 105 A PRO 106 n 92 PRO 106 A GLY 107 n 93 GLY 107 A GLU 108 n 94 GLU 108 A THR 109 n 95 THR 109 A PHE 110 n 96 PHE 110 A PHE 111 n 97 PHE 111 A MET 112 n 98 MET 112 A CYS 113 n 99 CYS 113 A SER 114 n 100 SER 114 A CYS 115 n 101 CYS 115 A SER 116 n 102 SER 116 A SER 117 n 103 SER 117 A ASP 118 n 104 ASP 118 A GLU 119 n 105 GLU 119 A CYS 120 n 106 CYS 120 A ASN 121 n 107 ASN 121 A ASP 122 n 108 ASP 122 A ASN 123 n 109 ASN 123 A ILE 124 n 110 ILE 124 A ILE 125 n 111 ILE 125 A PHE 126 n 112 PHE 126 A SER 127 n 113 SER 127 A GLU 128 n 114 GLU 128 A GLU 129 n 115 GLU 129 A TYR 130 n 116 TYR 130 A ASN 131 n 117 ASN 131 A THR 132 n 118 THR 132 A SER 133 n 119 SER 133 A ASN 134 n 120 ASN 134 A PRO 135 n 121 PRO 135 A ASP 136 n 122 ASP 136 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A N CYS 28 A N CYS 14 A O SER 52 A O SER 38 A N ARG 34 A N ARG 20 A O LEU 74 A O LEU 60 A O HIS 79 A O HIS 65 A N VAL 60 A N VAL 46 A N LYS 67 A N LYS 53 A O THR 109 A O THR 95 A N ARG 34 A N ARG 20 A O LEU 74 A O LEU 60 A O HIS 79 A O HIS 65 A N VAL 60 A N VAL 46 A N CYS 61 A N CYS 47 A O CYS 115 A O CYS 101 A N CYS 44 A N CYS 30 A O ILE 124 A O ILE 110 1 A A O H CYS SER 28 52 1.53 1 A A H O VAL HIS 60 79 1.59 1 A A H O ASN ASN 68 71 1.59 2 A A HE3 OD2 LYS ASP 29 122 0.89 2 A A HE3 CG LYS ASP 29 122 0.99 2 A A CE OD2 LYS ASP 29 122 1.09 2 A A HE2 OD2 LYS ASP 29 122 1.11 2 A A O OD1 ASN ASP 68 69 1.37 2 A A HE3 OD1 LYS ASP 29 122 1.47 2 A A O HG CYS SER 48 49 1.54 2 A A O H CYS SER 28 52 1.56 2 A A CE CG LYS ASP 29 122 1.66 2 A A O OD1 THR ASP 37 39 1.71 2 A A CD OD1 LYS ASP 29 122 1.90 2 A A CE OD1 LYS ASP 29 122 1.99 2 A A CD CG LYS ASP 29 122 2.19 3 A A OE1 H GLU THR 108 109 0.89 3 A A CD H GLU THR 108 109 1.41 3 A A OE1 N GLU THR 108 109 1.54 3 A A O H CYS SER 28 52 1.57 3 A A H O ALA CYS 63 113 1.58 3 A A O OE2 LYS GLU 67 108 1.82 5 A A OD1 H ASP VAL 32 33 1.09 5 A A CG H ASP VAL 32 33 1.39 5 A A OD1 N ASP VAL 32 33 1.39 5 A A H O SER ASP 46 122 1.53 5 A A OD1 N ASP ASN 17 18 1.68 5 A A C OD1 CYS ASP 38 39 1.80 5 A A O OD1 THR ASP 37 39 1.83 6 A A OE1 H GLU THR 108 109 1.33 6 A A CD H GLU THR 108 109 1.48 6 A A O OE2 LYS GLU 67 108 1.74 7 A A OD1 H ASP VAL 32 33 0.87 7 A A OE1 N GLU TYR 129 130 1.20 7 A A OD1 N ASP VAL 32 33 1.20 7 A A OE1 H GLU THR 108 109 1.46 7 A A CG H ASP VAL 32 33 1.46 7 A A HG2 OD2 GLU ASP 59 80 1.48 7 A A H O VAL HIS 60 79 1.57 7 A A O H VAL HIS 60 79 1.59 7 A A H O ARG LEU 34 74 1.60 8 A A HE3 OD2 LYS ASP 29 122 0.24 8 A A HZ1 OD1 LYS ASP 29 122 0.77 8 A A CE OD2 LYS ASP 29 122 1.16 8 A A HE3 CG LYS ASP 29 122 1.42 8 A A NZ OD1 LYS ASP 29 122 1.47 8 A A H O VAL HIS 60 79 1.59 8 A A OE1 HE3 GLU LYS 55 56 1.60 8 A A CE CG LYS ASP 29 122 1.69 8 A A CE OD1 LYS ASP 29 122 1.92 8 A A CD OD1 LYS ASP 29 122 1.93 8 A A NZ CG LYS ASP 29 122 1.93 8 A A CD CG LYS ASP 29 122 2.05 8 A A CD OD2 LYS ASP 29 122 2.09 8 A A NZ OD2 LYS ASP 29 122 2.14 9 A A OD1 H ASP GLU 69 70 0.70 9 A A OE1 H GLU THR 108 109 1.00 9 A A OD1 N ASP GLU 69 70 1.12 9 A A O OE2 LYS GLU 67 108 1.25 9 A A OD1 H ASP VAL 32 33 1.26 9 A A CD H GLU THR 108 109 1.37 9 A A OD1 N ASP VAL 32 33 1.48 9 A A CG H ASP VAL 32 33 1.49 9 A A CG H ASP GLU 69 70 1.55 9 A A H O LYS PHE 103 110 1.57 9 A A OE1 N GLU THR 108 109 1.61 9 A A C OE2 LYS GLU 67 108 2.13 10 A A HE3 OD2 LYS ASP 29 122 0.58 10 A A HB2 OE2 LYS GLU 105 108 0.89 10 A A CE OD2 LYS ASP 29 122 1.04 10 A A HB2 CD LYS GLU 105 108 1.04 10 A A CB OE2 LYS GLU 105 108 1.05 10 A A OE2 H GLU THR 129 132 1.10 10 A A HE2 OD2 LYS ASP 29 122 1.39 10 A A HB3 OE2 LYS GLU 105 108 1.42 10 A A HE3 CG LYS ASP 29 122 1.44 10 A A HB2 OE1 LYS GLU 105 108 1.51 10 A A OE1 N GLU TYR 129 130 1.52 10 A A OG H SER ASN 127 131 1.55 10 A A HG O SER LYS 95 97 1.56 10 A A H O LYS PHE 103 110 1.58 10 A A CG OE2 LYS GLU 105 108 1.70 10 A A CB CD LYS GLU 105 108 1.83 10 A A OE2 N GLU THR 129 132 2.03 10 A A CE CG LYS ASP 29 122 2.05 10 A A CD OD2 LYS ASP 29 122 2.13 10 A A CD OE2 LYS GLU 105 108 2.19 1 A ARG 34 0.240 SIDE CHAIN 1 A ARG 66 0.215 SIDE CHAIN 2 A ARG 34 0.240 SIDE CHAIN 2 A ARG 66 0.315 SIDE CHAIN 3 A ARG 34 0.316 SIDE CHAIN 3 A ARG 66 0.253 SIDE CHAIN 4 A ARG 34 0.297 SIDE CHAIN 4 A ARG 66 0.318 SIDE CHAIN 5 A ARG 34 0.313 SIDE CHAIN 5 A ARG 66 0.255 SIDE CHAIN 6 A ARG 34 0.298 SIDE CHAIN 6 A ARG 66 0.315 SIDE CHAIN 7 A ARG 34 0.245 SIDE CHAIN 7 A ARG 66 0.295 SIDE CHAIN 8 A ARG 34 0.262 SIDE CHAIN 8 A ARG 66 0.311 SIDE CHAIN 9 A ARG 34 0.286 SIDE CHAIN 9 A ARG 66 0.235 SIDE CHAIN 10 A ARG 34 0.169 SIDE CHAIN 10 A ARG 66 0.315 SIDE CHAIN 1 A VAL 22 -178.60 34.78 1 A ASP 32 68.84 -142.71 1 A ASP 39 -90.70 -95.57 1 A GLN 41 -77.88 -143.10 1 A LYS 42 55.32 102.46 1 A SER 43 43.51 84.23 1 A CYS 48 -147.89 -42.96 1 A VAL 60 -121.78 -166.94 1 A ASP 69 56.55 -77.58 1 A GLU 91 -159.96 7.88 1 A GLU 102 47.10 149.53 1 A CYS 113 -168.71 114.82 1 A ASP 118 -38.27 -101.17 1 A SER 127 -156.55 3.95 1 A GLU 128 58.36 -74.54 2 A ALA 19 52.90 174.46 2 A ALA 21 -172.20 -37.63 2 A ASP 32 80.89 -161.91 2 A ASN 40 32.66 95.84 2 A GLN 41 -160.86 -86.19 2 A LYS 42 -156.18 -55.57 2 A VAL 60 -114.96 -163.01 2 A ASP 69 66.99 -66.73 2 A GLU 70 -140.48 -21.90 2 A PRO 81 -82.38 49.41 2 A ASP 87 70.46 30.90 2 A GLU 91 -162.24 57.10 2 A ASP 92 -148.54 -0.86 2 A MET 100 55.11 99.29 2 A GLU 102 25.04 118.37 2 A CYS 113 -178.90 146.23 2 A GLU 119 53.00 78.87 2 A GLU 128 -157.51 -72.79 2 A TYR 130 -179.63 -29.40 2 A ASN 131 -172.29 58.01 2 A THR 132 54.10 -92.58 3 A ASP 32 80.43 -160.46 3 A ASN 40 34.08 95.12 3 A GLN 41 -161.92 -84.90 3 A LYS 42 -156.85 -57.43 3 A SER 46 60.34 148.08 3 A ASP 69 64.39 -68.49 3 A GLU 70 -131.66 -36.15 3 A HIS 86 69.48 -51.72 3 A ASP 87 -160.28 -18.46 3 A GLU 91 -159.92 64.47 3 A ASP 92 -151.12 3.85 3 A ILE 99 -66.94 75.59 3 A GLU 119 54.26 119.89 3 A CYS 120 -159.91 20.21 3 A SER 127 -158.67 -65.12 3 A GLU 128 59.70 -80.53 3 A GLU 129 -142.14 10.16 3 A ASN 134 54.24 80.06 4 A ASP 17 -153.58 77.52 4 A VAL 22 -131.85 -136.33 4 A LYS 23 62.35 135.15 4 A ASP 32 71.05 -154.66 4 A ASP 39 -92.05 -71.19 4 A ASN 40 32.40 100.86 4 A LYS 42 -154.58 -70.31 4 A VAL 60 -110.41 -161.36 4 A ASP 69 -165.30 -37.13 4 A GLU 91 -160.60 9.86 4 A GLU 102 45.89 155.31 4 A PRO 106 -84.94 40.82 4 A ASP 118 -39.74 -112.94 4 A GLU 119 -79.75 46.23 4 A CYS 120 -89.49 35.19 4 A GLU 128 59.04 -80.78 4 A GLU 129 -91.42 52.01 4 A TYR 130 35.44 60.63 4 A THR 132 55.90 -86.75 5 A ASP 17 51.81 -159.43 5 A ALA 19 -58.53 174.16 5 A VAL 22 57.62 -123.77 5 A ASP 32 74.21 -145.36 5 A ASP 39 28.37 -136.53 5 A SER 49 -158.14 31.87 5 A VAL 60 -111.08 -167.08 5 A GLU 70 86.37 45.08 5 A GLU 91 -162.46 15.36 5 A MET 100 59.42 91.66 5 A CYS 113 -174.40 135.41 5 A SER 117 -138.42 -76.91 5 A ASP 118 165.47 128.22 5 A CYS 120 -86.07 35.81 5 A SER 127 -157.99 29.36 5 A GLU 128 55.88 -85.93 5 A TYR 130 52.50 75.35 6 A LYS 23 -101.22 -67.35 6 A PHE 24 54.04 173.75 6 A PRO 25 -71.13 -90.42 6 A CYS 28 -162.04 -161.83 6 A ASP 32 69.56 -151.13 6 A GLN 41 -162.55 -32.07 6 A LYS 42 -153.63 -145.52 6 A SER 49 -157.66 19.91 6 A GLU 55 1.25 -59.11 6 A VAL 60 -112.40 -169.19 6 A ASP 69 67.76 -68.20 6 A GLU 70 -140.63 -17.99 6 A PRO 81 -75.45 -147.63 6 A LYS 82 66.49 -58.37 6 A GLU 91 -163.56 13.86 6 A GLU 102 45.26 157.18 6 A PRO 106 -78.57 23.77 6 A CYS 113 -162.82 112.16 6 A GLU 119 57.36 121.36 6 A CYS 120 -141.31 -22.95 6 A SER 127 -158.13 -36.74 6 A GLU 128 54.99 -102.81 6 A ASN 131 -54.90 88.68 6 A ASN 134 54.68 71.17 7 A THR 16 64.88 -68.36 7 A PHE 24 56.63 164.59 7 A ASP 32 73.55 -150.36 7 A ARG 34 -116.76 -165.10 7 A CYS 38 -63.96 72.63 7 A SER 43 81.99 154.47 7 A ASP 69 66.79 -68.55 7 A LEU 90 -161.76 79.79 7 A MET 100 -68.92 88.10 7 A GLU 102 74.30 129.57 7 A ASP 118 -40.50 -105.49 7 A GLU 128 53.17 -89.50 7 A ASN 131 -93.91 30.64 8 A ALA 21 66.73 -61.14 8 A ASP 32 67.87 -147.89 8 A CYS 38 -179.69 64.04 8 A ASN 40 -178.58 126.67 8 A GLN 41 -79.81 20.97 8 A SER 43 81.30 156.68 8 A ASP 69 57.74 -76.32 8 A ILE 89 -85.11 -142.58 8 A LEU 90 -161.60 -50.97 8 A ASP 92 -149.76 -13.69 8 A GLU 102 78.38 127.95 8 A GLU 119 59.62 133.06 8 A CYS 120 -175.41 -24.10 8 A SER 127 -157.85 53.48 8 A GLU 128 55.39 -92.01 8 A GLU 129 -101.01 -61.34 8 A TYR 130 -169.00 72.77 8 A THR 132 45.10 24.47 8 A SER 133 177.08 -33.03 8 A ASN 134 53.96 73.61 9 A PHE 24 61.47 137.93 9 A ASP 32 70.02 -150.23 9 A CYS 38 -62.02 90.51 9 A ASP 39 -112.83 -159.88 9 A ASN 40 37.67 -96.34 9 A GLN 41 -163.86 -130.74 9 A LYS 42 63.52 -5.04 9 A SER 43 74.92 155.18 9 A ASP 69 55.12 -82.13 9 A GLU 91 -162.81 9.61 9 A GLU 102 75.84 126.60 9 A GLU 119 47.28 79.66 9 A SER 127 -157.93 -126.03 9 A GLU 128 58.65 -86.39 9 A SER 133 82.38 -21.59 9 A ASN 134 30.35 54.36 10 A ASN 18 60.44 152.10 10 A LYS 23 -67.74 -148.55 10 A PHE 24 61.74 164.75 10 A PHE 30 -115.87 73.38 10 A ASP 32 -41.73 -142.85 10 A ASP 39 -174.63 -139.60 10 A GLN 41 -162.73 -90.77 10 A LYS 42 -156.30 46.52 10 A SER 43 76.66 156.81 10 A SER 49 -158.56 29.31 10 A GLU 55 1.78 -58.35 10 A VAL 60 -113.68 -166.86 10 A ASP 69 64.58 -71.15 10 A GLU 91 -159.60 31.20 10 A GLU 102 77.83 121.54 10 A ASP 118 -40.49 -111.37 10 A GLU 128 59.78 -76.03 10 A TYR 130 53.72 72.74 10 A THR 132 50.16 -100.16 TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR EXTRACELLULAR DOMAIN 1 N N disulf 2.018 A CYS 28 A SG CYS 14 1_555 A CYS 61 A SG CYS 47 1_555 disulf 2.018 A CYS 31 A SG CYS 17 1_555 A CYS 48 A SG CYS 34 1_555 disulf 2.018 A CYS 38 A SG CYS 24 1_555 A CYS 44 A SG CYS 30 1_555 disulf 2.019 A CYS 54 A SG CYS 40 1_555 A CYS 78 A SG CYS 64 1_555 disulf 2.019 A CYS 98 A SG CYS 84 1_555 A CYS 113 A SG CYS 99 1_555 disulf 2.022 A CYS 115 A SG CYS 101 1_555 A CYS 120 A SG CYS 106 1_555 Cytokine receptor Three-Finger Toxin Fold, Cytokine receptor TGFR2_HUMAN UNP 1 38 P37173 VTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAA SPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPD 38 159 1PLO 15 136 P37173 A 1 1 122 1 ASN engineered mutation ALA 19 1PLO A P37173 UNP 42 5 2 4 4 2 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A LEU 27 A LEU 13 A LYS 29 A LYS 15 A THR 51 A THR 37 A ILE 53 A ILE 39 A ASP 32 A ASP 18 A PHE 35 A PHE 21 A ILE 72 A ILE 58 A HIS 79 A HIS 65 A VAL 60 A VAL 46 A LYS 67 A LYS 53 A THR 109 A THR 95 A PHE 110 A PHE 96 A ASP 32 A ASP 18 A PHE 35 A PHE 21 A ILE 72 A ILE 58 A HIS 79 A HIS 65 A VAL 60 A VAL 46 A LYS 67 A LYS 53 A SER 114 A SER 100 A CYS 115 A CYS 101 A CYS 44 A CYS 30 A MET 45 A MET 31 A ASN 123 A ASN 109 A ILE 124 A ILE 110